2021 Publications

  1. M. Abrantes, B. Nogueira-Garcia, M. Alves, D. Teixeira Passos, D. Brito, F. J. Pinto, & D. Caldeira. (2021). Low-Dose Colchicine in Coronary Artery Disease - Systematic Review and Meta-Analysis. Circ Rep, 3(8), 457-464. doi:10.1253/circrep.CR-21-0065.
  2. Aguiar-Ricardo, J. Agostinho, A. Pereira, F. Rodrigues, D. Brito, F. J. Pinto, C. Catarino, & M. Mendes Pedro. (2021). Acute coronay syndrome in a patient with severe hemophilia A: Dificult decisions. Rev Port Cardiol (Engl Ed), 40(12), 985.e981-985.e985. doi:10.1016/j.repce.2021.10.002.
  3. G. Almeida. (2021). Coronary Artery Calcium: Predicting Prognosis after Transcatheter Aortic Valve Replacement. Radiology, 301(1), 113-114. doi:10.1148/radiol.2021211526.
  4. G. Almeida, N. António, C. Saraiva, A. M. Ferreira, A. H. Reis, H. Marques, N. D. Ferreira, & M. Oliveira. (2021). Consensus document on magnetic resonance imaging in patients with cardiac implanted electronic devices. Rev Port Cardiol (Engl Ed), 40(1), 41-52. doi:10.1016/j.repc.2020.05.009.
  5. G. Almeida, N. António, C. Saraiva, A. M. Ferreira, A. H. Reis, H. Marques, N. D. Ferreira, & M. Oliveira. (2021). Consensus document on magnetic resonance imaging in patients with cardiac implanted electronic devices. Rev Port Cardiol (Engl Ed), 40(1), 41-52. doi:10.1016/j.repc.2020.05.009.
  6. G. Almeida, J. P. Carpenter, M. Cameli, E. Donal, M. R. Dweck, F. A. Flachskampf, A. M. Maceira, D. Muraru, D. Neglia, A. Pasquet, S. Plein, & B. L. Gerber. (2021). Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging, 22(8), e97-e125. doi:10.1093/ehjci/jeab053.
  7. I Almeida, H Miranda, H Santos, M Santos, J Chin, C Sousa, & L Almeida. (2021). Prognostic value of BNP in STEMI patients. European Heart Journal. Acute Cardiovascular Care, 10(Supplement_1). doi:10.1093/ehjacc/zuab020.093.
  8. M. Alves, A. M. Abrantes, G. Portugal, M. M. Cruz, S. Reimão, D. Caldeira, J. M. Ferro, & J. J. Ferreira. (2021). Does Parkinson’s Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study. Front Neurol, 12, 633900. doi:10.3389/fneur.2021.633900.
  9. M. Alves, P. Pita Lobo, L. A. Kauppila, L. Rebordão, M. M. Cruz, F. Soares, J. Cruz, A. Tornada, D. Caldeira, S. Reimão, V. Oliveira, J. M. Ferro, & J. J. Ferreira. (2021). Cardiovascular and cerebrovascular risk markers in Parkinson’s disease: Results from a case-control study. Eur J Neurol, 28(8), 2669-2679. doi:10.1111/ene.14938.
  10. M. Alves, L. Prada, J. Costa, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis. Eur J Emerg Med, 28(1), 11-18. doi:10.1097/mej.0000000000000764.
  11. M. Ambrosetti, A. Abreu, V. Cornelissen, D. Hansen, M. C. Iliou, H. Kemps, R. F. E. Pedretti, H. Voller, M. Wilhelm, M. F. Piepoli, C. G. Beccaluva, P. Beckers, T. Berger, C. H. Davos, P. Dendale, W. Doehner, I. Frederix, D. Gaita, A. Gevaert, E. Kouidi, N. Kraenkel, J. Laukkanen, F. Maranta, A. Mazza, M. Mendes, D. Neunhaeuserer, J. Niebauer, B. Pavy, C. P. Gil, B. Rauch, S. Sarzi Braga, M. Simonenko, A. Cohen-Solal, M. Sommaruga, E. Venturini, & C. Vigorito. (2021). Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era. Eur J Prev Cardiol, 28(5), 541-557. doi:10.1093/eurjpc/zwaa080.
  12. M. Ambrosetti, A. Abreu, V. Cornelissen, D. Hansen, M. C. Iliou, H. Kemps, R. F. E. Pedretti, H. Voller, M. Wilhelm, M. F. Piepoli, C. G. Beccaluva, P. Beckers, T. Berger, C. H. Davos, P. Dendale, W. Doehner, I. Frederix, D. Gaita, A. Gevaert, E. Kouidi, N. Kraenkel, J. Laukkanen, F. Maranta, A. Mazza, M. Mendes, D. Neunhaeuserer, J. Niebauer, B. Pavy, C. P. Gil, B. Rauch, S. Sarzi Braga, M. Simonenko, A. Cohen-Solal, M. Sommaruga, E. Venturini, & C. Vigorito. (2021). Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era. Eur J Prev Cardiol, 28(5), 541-557. doi:10.1093/eurjpc/zwaa080.
  13. M. M. Antunes, M. Alves, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis. Cardiovasc Drugs Ther, 35(4), 871-873. doi:10.1007/s10557-020-07093-8.
  14. M. M. Antunes, M. Alves, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis. Cardiovasc Drugs Ther, 35(4), 871-873. doi:10.1007/s10557-020-07093-8.
  15. M. M. Antunes, M. Alves, F. J. Pinto, G. Agnelli, & D. Caldeira. (2021). The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis. European Journal of Internal Medicine, 94, 45-55. doi:10.1016/j.ejim.2021.10.014.
  16. S. Barco, I. Schmidtmann, W. Ageno, T. Anušić, R. M. Bauersachs, C. Becattini, E. Bernardi, J. Beyer-Westendorf, L. Bonacchini, J. Brachmann, M. Christ, M. Czihal, D. Duerschmied, K. Empen, C. Espinola-Klein, J. H. Ficker, C. Fonseca, S. Genth-Zotz, D. Jiménez, V. P. Harjola, M. Held, L. Iogna Prat, T. J. Lange, M. Lankeit, A. Manolis, A. Meyer, T. Münzel, P. Mustonen, U. Rauch-Kroehnert, P. Ruiz-Artacho, S. Schellong, M. Schwaiblmair, R. Stahrenberg, L. Valerio, P. E. Westerweel, P. S. Wild, & S. V. Konstantinides. (2021). Survival and quality of life after early discharge in low-risk pulmonary embolism. Eur Respir J, 57(2). doi:10.1183/13993003.02368-2020.
  17. W. H. Beijnink, T. Thim, D. J. van der Heijden, I. Klem, R. Al-Lamee, J. L. Vos, Y. Koop, M. G. W. Dijkgraaf, M. A. M. Beijk, R. J. Kim, J. Davies, L. Raposo, S. B. Baptista, J. Escaned, J. J. Piek, M. Maeng, N. van Royen, & R. Nijveldt. (2021). Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial. BMJ Open, 11(1), e044035. doi:10.1136/bmjopen-2020-044035.
  18. J. Bernardo, J. Gonçalves, J. Gameiro, J. Oliveira, F. Marques, I. Duarte, C. Branco, C. Costa, C. Carreiro, J. N. Fonseca, S. Braz, & J. A. Lopes. (2021). The impact of transient and persistent acute kidney injury in hospital mortality in COVID-19 patients. J Bras Nefrol. doi:10.1590/2175-8239-jbn-2021-0123.
  19. M Borges, M Lemos Pires, R Pinto, G De Sa, I Ricardo, N Cunha, P Alves Da Silva, M Linan Pinto, C Sousa Guerreiro, FJ Pinto, A Abreu, & H Santa-Clara. (2021). COVID-19 era in long-term cardiac rehabilitation programs: how was muscle strenght and lean mass affected in cardiovascular patients? European Journal of Preventive Cardiology, 28(Supplement_1). doi:10.1093/eurjpc/zwab061.362.
  20. G. Branco, I. Duarte, J. Gameiro, C. Costa, F. Marques, J. Oliveira, J. Bernardo, J. N. Fonseca, C. Carreiro, S. Braz, & J. A. Lopes. (2021). Presentation and outcomes of chronic kidney disease patients with COVID-19. J Bras Nefrol. doi:10.1590/2175-8239-jbn-2021-0071.
  21. G. Branco, I. Duarte, J. Gameiro, C. Costa, F. Marques, J. Oliveira, J. Bernardo, J. N. Fonseca, C. Carreiro, S. Braz, & J. A. Lopes. (2021). Presentation and outcomes of chronic kidney disease patients with COVID-19. J Bras Nefrol. doi:10.1590/2175-8239-jbn-2021-0071.
  22. D. Brito. (2021). Remote monitoring of heart failure patients: A complex proximity. Rev Port Cardiol (Engl Ed), 40(5), 353-356. doi:10.1016/j.repce.2021.06.003.
  23. J Brito, T Rodigues, A Nunes-Ferreira, P Silverio Antonio, S Couto Pereira, B Valente Silva, P Alves Da Silva, C Barreiros, G Lima Da Silva, L Carpinteiro, N Cortez-Dias, F J Pinto, & J Sousa. (2021). Can we use the CHA2DS2VASc score in Atrial Flutter? EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.307.
  24. S. C. Butcher, F. Fortuni, W. Kong, E. M. Vollema, F. Prevedello, R. Perry, A. C. T. Ng, K. K. Poh, A. G. Almeida, A. González-Gómez, M. Shen, T. C. Yeo, M. Shanks, B. A. Popescu, L. Galian-Gay, M. Fijalkowski, M. Liang, E. Tay, N. Ajmone Marsan, J. B. Selvanayagam, F. J. Pinto, J. Zamorano, P. Pibarot, A. Evangelista, J. J. Bax, & V. Delgado. (2021). Prognostic implications of left atrial dilation in aortic regurgitation due to bicuspid aortic valve. Heart. doi:10.1136/heartjnl-2020-318907.
  25. J. Butler, S. D. Anker, T. J. Siddiqi, A. J. S. Coats, F. Dorigotti, G. Filippatos, T. Friede, U. M. Göhring, M. N. Kosiborod, L. H. Lund, M. Metra, C. Moreno Quinn, I. L. Piña, F. J. Pinto, P. Rossignol, P. Szecsödy, P. Van Der Meer, M. Weir, & B. Pitt. (2022). Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. Eur J Heart Fail, 24(1), 230-238. doi:10.1002/ejhf.2386.
  26. D. Caldeira, P. Broeiro, F. Cimadeira, J. Costa, A. Lourenço, C. Meireles, M. P. Guerreiro, & N. Ribeiro. (2021). Opioids prescribing trend between 2013 and 2017 in the Lisbon and Tagus Valley region, Portugal. Int J Clin Pharm, 43(2), 323-327. doi:10.1007/s11096-020-01199-7.
  27. D. Caldeira, & F. J. Pinto. (2021). COVID-19 and myocardial infarction. Lancet, 398(10315), 1963-1964.
  28. R Caldeira Da Rocha, R Carvalho, A Ferreira, T Rodrigues, G Silva, N Cortez Dias, L Carpinteiro, FAUSTO Pinto, & J De Sousa. (2021). Comparing single approaches success in index atrial fibrillation ablation. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.261.
  29. V. L. Cammann, J. F. Scheitz, R. von Rennenberg, L. Jäncke, C. H. Nolte, K. A. Szawan, H. Stengl, M. Würdinger, M. Endres, C. Templin, & J. R. Ghadri. (2021). Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome. Sci Rep, 11(1), 23555. doi:10.1038/s41598-021-01496-9.
  30. J. Costa, J. Alarcão, A. Amaral-Silva, F. Araújo, R. Ascenção, D. Caldeira, M. F. Cardoso, M. Correia, F. Fiorentino, C. Gavina, V. Gil, M. Gouveia, F. Lourenço, E. Silva A. Mello, L. Mendes Pedro, J. Morais, A. Vaz-Carneiro, M. T. Veríssimo, & M. Borges. (2021). Atherosclerosis: The cost of illness in Portugal. Rev Port Cardiol (Engl Ed), 40(6), 409-419. doi:10.1016/j.repce.2020.08.003.
  31. J. Costa, J. Alarcão, F. Araujo, R. Ascenção, D. Caldeira, F. Fiorentino, V. Gil, M. Gouveia, F. Lourenço, E. Silva A. Mello, F. Sampaio, A. Vaz Carneiro, & M. Borges. (2021). The burden of atherosclerosis in Portugal. Eur Heart J Qual Care Clin Outcomes, 7(2), 154-162. doi:10.1093/ehjqcco/qcaa060.
  32. S Couto Pereira, T Rodrigues, J Brito, P Silverio Antonio, B Valente Silva, P Alves Da Silva, C Barreiros, G Lima Da Silva, L Carpinteiro, N Cortez-Dias, FJ Pinto, & J De Sousa. (2021). Catheter ablation of long-standing persistent atrial fibrillation: the ugly type of AF? EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.087.
  33. S Couto Pereira, T Rodrigues, J Brito, P Silverio Antonio, B Valente Silva, P Alves Da Silva, N Cunha, A Nunes-Ferreira, A Bernardes, G Lima Da Silva, N Cortez-Dias, FJ Pinto, & J De Sousa. (2021). Withdrawal of anti-arrhythmic therapy after cavo-tricuspid isthmus ablation of typical atrial flutter. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.054.
  34. S Couto Pereira, P Silverio Antonio, B Valente Silva, J Brito, T Rodrigues, P Alves Da Silva, A Veiga, J Ferro, FJ Pinto, C Fonseca, & AG Almeida. (2021). Electrocardiographic markers of incident atrial fibrillation in patients with cryptogenic stroke. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.018.
  35. de Mello Sampayo, M. Fiuza, F. Pinto, & J. Fontes. (2021). Cost-effectiveness of cardio-oncology clinical assessment for prevention of chemotherapy-induced cardiotoxicity. Rev Port Cardiol (Engl Ed), 40(7), 475-483. doi:10.1016/j.repce.2021.07.016.
  36. de Sousa, & F. J. Pinto. (2022). Dapaglifozin post transcatheter aortic valve implantation: the need for further evidence. Eur J Heart Fail. doi:10.1002/ejhf.2436.
  37. de Sousa, R. M. Ribeiro, & F. J. Pinto. (2021). The burden of infective endocarditis in Portugal in the last 30 years – a systematic review of observational studies. Rev Port Cardiol (Engl Ed), 40(3), 205-217. doi:10.1016/j.repc.2020.07.014.
  38. De Sousa, R. M. Ribeiro, & F. J. Pinto. (2021). Infective Endocarditis as the Cause of Death: A Populationbased Study in Portugal, from 2002 to 2018. Acta Med Port. doi:10.20344/amp.14609.
  39. Duarte, J. Gameiro, C. Outerelo, E. Nogueira, & J. A. Lopes. (2021). Atypical Hemolytic Uremic Syndrome and Nephrotic Syndrome Associated with Cytomegalovirus Infection. Nephron, 145(2), 188-191. doi:10.1159/000511833.
  40. M. P. Dubé, M. A. Legault, A. Lemaçon, L. P. Lemieux Perreault, R. Fouodjio, D. D. Waters, S. Kouz, F. J. Pinto, A. P. Maggioni, R. Diaz, C. Berry, W. Koenig, J. Lopez-Sendon, H. Gamra, G. S. Kiwan, G. Asselin, S. Provost, A. Barhdadi, M. Sun, M. Cossette, L. Blondeau, I. Mongrain, A. Dubois, D. Rhainds, N. Bouabdallaoui, M. Samuel, S. de Denus, P. L. L’Allier, M. C. Guertin, F. Roubille, & J. C. Tardif. (2021). Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT. Circ Genom Precis Med, 14(2), e003183. doi:10.1161/circgen.120.003183.
  41. Egídio de Sousa, A. Pedroso, B. Chambino, M. Roldão, F. Pinto, R. Guerreiro, I. Araújo, C. Henriques, & C. Fonseca. (2021). Palliative Care in Heart Failure: Challenging Prognostication. Cureus, 13(9), e18301. doi:10.7759/cureus.18301.
  42. El-Battrawy, V. L. Cammann, K. Kato, K. A. Szawan, D. Di Vece, A. Rossi, M. Wischnewsky, J. Hermes-Laufer, S. Gili, R. Citro, E. Bossone, M. Neuhaus, J. Franke, B. Meder, M. Jaguszewski, M. Noutsias, M. Knorr, S. Heiner, F. D’Ascenzo, W. Dichtl, C. Burgdorf, B. Kherad, C. Tschöpe, A. Sarcon, J. Shinbane, L. Rajan, G. Michels, R. Pfister, A. Cuneo, C. Jacobshagen, M. Karakas, W. Koenig, A. Pott, P. Meyer, J. David Arroja, A. Banning, F. Cuculi, R. Kobza, T. A. Fischer, T. Vasankari, K. E. J. Airaksinen, L. C. Napp, M. Budnik, R. Dworakowski, P. MacCarthy, C. Kaiser, S. Osswald, L. Galiuto, C. Chan, P. Bridgman, D. Beug, C. Delmas, O. Lairez, E. Gilyarova, A. Shilova, M. Gilyarov, M. Kozel, P. Tousek, D. E. Winchester, J. Galuszka, C. Ukena, G. Poglajen, P. Carrilho-Ferreira, C. Hauck, C. Paolini, C. Bilato, Y. Kobayashi, A. Prasad, C. S. Rihal, K. Liu, P. C. Schulze, M. Bianco, L. Jörg, H. Rickli, G. Pestana, T. H. Nguyen, M. Böhm, L. S. Maier, F. J. Pinto, P. Widimský, S. B. Felix, G. Opolski, R. C. Braun-Dullaeus, W. Rottbauer, G. Hasenfuß, B. M. Pieske, H. Schunkert, H. Thiele, J. Bauersachs, H. A. Katus, J. D. Horowitz, C. Di Mario, T. Münzel, F. Crea, J. J. Bax, T. F. Lüscher, F. Ruschitzka, F. Duru, M. Borggrefe, J. R. Ghadri, I. Akin, & C. Templin. (2021). Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry. J Am Heart Assoc, 10(15), e014059. doi:10.1161/jaha.119.014059.
  43. L. B. Elvas, A. G. Almeida, L. Rosario, M. S. Dias, & J. C. Ferreira. (2021). Calcium Identification and Scoring Based on Echocardiography. An Exploratory Study on Aortic Valve Stenosis. J Pers Med, 11(7). doi:10.3390/jpm11070598.
  44. C. Faria, J. M. Lee, T. van der Hoef, H. Mejía-Rentería, M. Echavarría-Pinto, S. B. Baptista, E. Cerrato, H. M. Garcia-Garcia, J. Davies, Y. Onuma, H. Samady, J. J. Piek, P. W. Serruys, A. Lerman, & J. Escaned. (2021). Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial. EuroIntervention, 17(9), 757-764. doi:10.4244/eij-d-20-01163.
  45. L. R. Ferat, R. Forrest, K. Sehmi, R. D. Santos, D. Stewart, A. J. M. Boulton, B. Y. Jiménez, P. Riley, D. Burger, E. S. W. Jones, M. Tomaszewski, M. R. Milanese, P. Laffin, V. Jha, B. Borisch, M. Moore, F. J. Pinto, D. Piñeiro, J. L. Eiselé, D. T. Lackland, P. K. Whelton, X. H. Zhang, A. Stavdal, D. Li, R. Hobbs, J. D. Pandian, M. Brainin, & V. Feigin. (2021). Preventing the Next Pandemic: The Case for Investing in Circulatory Health – A Global Coalition for Circulatory Health Position Paper. Glob Heart, 16(1), 66. doi:10.5334/gh.1077.
  46. N. Fernandes, L. Prada, M. M. Rosa, J. J. Ferreira, J. Costa, F. J. Pinto, & D. Caldeira. (2021). The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis. Clin Res Cardiol, 110(2), 183-193. doi:10.1007/s00392-020-01697-8.
  47. C. Fonseca, A. G. Almeida, M. O. Santos, & J. M. Ferro. (2021). Neurological complications of cardiomyopathies. Handb Clin Neurol, 177, 91-109. doi:10.1016/b978-0-12-819814-8.00001-9.
  48. C. Fonseca, J. M. Ferro, & A. G. Almeida. (2021). Cardiovascular magnetic resonance imaging and its role in the investigation of stroke: an update. J Neurol, 268(7), 2597-2604. doi:10.1007/s00415-020-10393-6.
  49. J. A. Fonseca, J. Gameiro, I. Duarte, S. Jorge, & J. A. Lopes. (2021). The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study. Nefrologia (Engl Ed), 41(3), 321-328. doi:10.1016/j.nefro.2020.07.013.
  50. Freedman, G. Hindricks, A. Banerjee, A. Baranchuk, C. K. Ching, X. Du, D. Fitzsimons, J. S. Healey, T. Ikeda, T. C. A. Lobban, A. Mbakwem, C. Narasimhan, L. Neubeck, P. Noseworthy, D. M. Philbin, Jr., F. J. Pinto, J. Rwebembera, R. B. Schnabel, J. H. Svendsen, L. Aguinaga, E. Arbelo, M. Böhm, H. A. Farhan, F. D. R. Hobbs, A. Martínez-Rubio, C. Militello, N. Naik, J. J. Noubiap, P. Perel, D. J. Piñeiro, A. L. Ribeiro, & J. Stepinska. (2021). World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update. Glob Heart, 16(1), 41. doi:10.5334/gh.1023.
  51. T. Freitas, C. Calhau, G. Antunes, B. Araújo, M. Bandeira, S. Barreira, F. Bazenga, S. Braz, D. Caldeira, S. C. R. Santos, A. Faria, D. Faria, M. Fraga, B. Nogueira-Garcia, L. Gonçalves, P. Kovalchuk, L. Lacerda, H. Lopes, D. Luís, F. Medeiros, A. M. P. Melo, J. Melo-Cristino, A. Miranda, C. Pereira, A. T. Pinto, J. Pinto, H. Proença, A. Ramos, J. P. R. Rato, F. Rocha, J. C. Rocha, A. Moreira-Rosário, H. Vazão, Y. Volovetska, J. T. Guimarães, & F. J. Pinto. (2021). Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep, 11(1), 20837. doi:10.1038/s41598-021-99952-z.
  52. S. Gamboa Madeira, C. Fernandes, T. Paiva, C. Santos Moreira, & D. Caldeira. (2021). The Impact of Different Types of Shift Work on Blood Pressure and Hypertension: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health, 18(13). doi:10.3390/ijerph18136738.
  53. J. Gameiro, C. Carreiro, J. A. Fonseca, M. Pereira, S. Jorge, J. Gouveia, & J. A. Lopes. (2021). Acute kidney disease and long-term outcomes in critically ill acute kidney injury patients with sepsis: a cohort analysis. Clin Kidney J, 14(5), 1379-1387. doi:10.1093/ckj/sfaa130.
  54. J. Gameiro, J. A. Fonseca, J. Oliveira, F. Marques, J. Bernardo, C. Costa, C. Carreiro, S. Braz, & J. A. Lopes. (2021). Acute kidney injury in hospitalized patients with COVID-19: A Portuguese cohort. Nefrologia, 41(6), 689-698. doi:10.1016/j.nefro.2021.04.002.
  55. J. Gameiro, F. Marques, & J. A. Lopes. (2021). Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J, 14(3), 789-804. doi:10.1093/ckj/sfaa177.
  56. J. Gameiro, F. Marques, & J. A. Lopes. (2021). Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J, 14(3), 789-804. doi:10.1093/ckj/sfaa177.
  57. Gao, C. David, M. M. Rosa, J. Costa, F. J. Pinto, & D. Caldeira. (2021). The Risk of Mortality Associated With Opioid Use in Patients With Acute Heart Failure: Systematic Review and Meta-analysis. J Cardiovasc Pharmacol, 77(2), 123-129. doi:10.1097/fjc.0000000000000954.
  58. P. Garcia-Pavia, F. Bengel, D. Brito, T. Damy, F. Duca, S. Dorbala, J. Nativi-Nicolau, L. Obici, C. Rapezzi, Y. Sekijima, & P. M. Elliott. (2021). Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail, 23(6), 895-905. doi:10.1002/ejhf.2198.
  59. Gasecka, J. A. Borovac, R. A. Guerreiro, M. Giustozzi, W. Parker, D. Caldeira, & G. Chiva-Blanch. (2021). Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther, 35(2), 215-229. doi:10.1007/s10557-020-07084-9.
  60. Melo R. Gouveia, B. Martins, D. M. Pedro, C. M. Santos, A. Duarte, E. Fernandes R. Fernandes, P. Garrido, & L. Mendes Pedro. (2021). Microbial evolution of vascular graft infections in a tertiary hospital based on positive graft cultures. J Vasc Surg, 74(1), 276-284 e274. doi:10.1016/j.jvs.2020.12.071.
  61. Melo R. Gouveia, M. Rodrigues, D. Caldeira, M. Alves, E. Fernandes R. Fernandes, & L. Mendes Pedro. (2021). Doxycycline is not Effective in Reducing Abdominal Aortic Aneurysm Growth: A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg, 61(5), 863-864. doi:10.1016/j.ejvs.2021.01.023.
  62. Melo R. Gouveia, G. Silva Duarte, A. Lopes, M. Alves, D. Caldeira, E. Fernandes R. Fernandes, & L. Mendes Pedro. (2021). Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies. Semin Thorac Cardiovasc Surg. doi:10.1053/j.semtcvs.2021.02.029.
  63. TE Graca Rodrigues, J Brito, P Silverio-Antonio, P Couto Pereira, B Valente Silva, P Alves Da Silva, N Cunha, A Nunes-Ferreira, J Ribeiro, G Lima Da Silva, L Carpinteiro, N Cortez-Dias, FJ Pinto, & J Sousa. (2021). Long-term risk of major cardiovascular events after cavotricuspid isthmus ablation: when and in whom to discontinue oral anticoagulation? EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.305.
  64. D. Hansen, A. Abreu, M. Ambrosetti, V. Cornelissen, A. Gevaert, H. Kemps, J. A. Laukkanen, R. Pedretti, M. Simonenko, M. Wilhelm, C. H. Davos, W. Doehner, M. C. Iliou, N. Krankel, H. Voller, & M. Piepoli. (2021). Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. doi:10.1093/eurjpc/zwab007.
  65. Hanssen, H. Boardman, A. Deiseroth, T. Moholdt, M. Simonenko, N. Krankel, J. Niebauer, M. Tiberi, A. Abreu, E. E. Solberg, L. Pescatello, J. Brguljan, A. Coca, & P. Leeson. (2021). Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension. Eur J Prev Cardiol. doi:10.1093/eurjpc/zwaa141.
  66. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J. J. Bax, C. Blomstrom-Lundqvist, G. Boriani, M. Castella, G. A. Dan, P. E. Dilaveris, L. Fauchier, G. Filippatos, J. M. Kalman, M. La Meir, D. A. Lane, J. P. Lebeau, M. Lettino, G. Y. H. Lip, F. J. Pinto, G. N. Thomas, M. Valgimigli, I. C. Van Gelder, B. P. Van Putte, & C. L. Watkins. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 42(5), 373-498. doi:10.1093/eurheartj/ehaa612.
  67. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J. J. Bax, C. Blomstrom-Lundqvist, G. Boriani, M. Castella, G. A. Dan, P. E. Dilaveris, L. Fauchier, G. Filippatos, J. M. Kalman, M. La Meir, D. A. Lane, J. P. Lebeau, M. Lettino, G. Y. H. Lip, F. J. Pinto, G. N. Thomas, M. Valgimigli, I. C. Van Gelder, B. P. Van Putte, C. L. Watkins, & E. S. C. Scientific Document Group. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J, 42(5), 373-498. doi:10.1093/eurheartj/ehaa612.
  68. S. Honarbakhsh, R. Providencia, J. Garcia-Hernandez, C. A. Martin, R. J. Hunter, W. Y. Lim, C. Kirkby, A. J. Graham, A. Sharifzadehgan, V. Waldmann, E. Marijon, C. Munoz-Esparza, J. Lacunza, J. R. Gimeno-Blanes, B. Ankou, P. Chevalier, N. Antonio, L. Elvas, S. Castelletti, L. Crotti, P. Schwartz, M. Scanavacca, F. Darrieux, L. Sacilotto, J. Mueller-Leisse, C. Veltmann, A. Vicentini, A. Demarchi, N. Cortez-Dias, P. S. Antonio, J. de Sousa, P. Adragao, D. Cavaco, F. M. Costa, Z. Khoueiry, S. Boveda, M. J. Sousa, Z. Jebberi, P. Heck, S. Mehta, G. Conte, T. Ozkartal, A. Auricchio, M. D. Lowe, R. J. Schilling, D. Prieto-Merino, P. D. Lambiase, & Investigators Brugada Syndrome Risk. (2021). A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC Clin Electrophysiol, 7(2), 210-222. doi:10.1016/j.jacep.2020.08.032.
  69. Y. Imori, K. Kato, V. L. Cammann, K. A. Szawan, M. Wischnewsky, S. Dreiding, M. Wurdinger, M. Schonberger, V. Petkova, D. Niederseer, R. A. Levinson, D. Di Vece, S. Gili, B. Seifert, M. Wakita, N. Suzuki, R. Citro, E. Bossone, S. Heiner, M. Knorr, T. Jansen, T. Munzel, F. D’Ascenzo, J. Franke, I. Sorici-Barb, H. A. Katus, A. Sarcon, J. Shinbane, L. C. Napp, J. Bauersachs, M. Jaguszewski, R. Shiomura, S. Nakamura, H. Takano, M. Noutsias, C. Burgdorf, I. Ishibashi, T. Himi, W. Koenig, H. Schunkert, H. Thiele, B. Kherad, C. Tschope, B. M. Pieske, L. Rajan, G. Michels, R. Pfister, S. Mizuno, A. Cuneo, C. Jacobshagen, G. Hasenfuss, M. Karakas, H. Mochizuki, A. Pott, W. Rottbauer, S. M. Said, R. C. Braun-Dullaeus, A. Banning, T. Isogai, A. Kimura, F. Cuculi, R. Kobza, T. A. Fischer, T. Vasankari, K. E. J. Airaksinen, Y. Tomita, M. Budnik, G. Opolski, R. Dworakowski, P. MacCarthy, C. Kaiser, S. Osswald, L. Galiuto, F. Crea, W. Dichtl, T. Murakami, Y. Ikari, K. Empen, D. Beug, S. B. Felix, C. Delmas, O. Lairez, T. Yamaguchi, I. El-Battrawy, I. Akin, M. Borggrefe, J. D. Horowitz, M. Kozel, P. Tousek, P. Widimsky, E. Gilyarova, A. Shilova, M. Gilyarov, M. Neuhaus, P. Meyer, J. D. Arroja, C. Chan, P. Bridgman, J. Galuszka, G. Poglajen, P. Carrilho-Ferreira, F. J. Pinto, C. Hauck, L. S. Maier, K. Liu, C. Di Mario, C. Paolini, C. Bilato, M. Bianco, L. Jorg, H. Rickli, D. E. Winchester, C. Ukena, M. Bohm, J. J. Bax, A. Prasad, C. S. Rihal, S. Saito, Y. Kobayashi, T. F. Luscher, F. Ruschitzka, W. Shimizu, J. R. Ghadri, & C. Templin. (2021). Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry. Clin Res Cardiol. doi:10.1007/s00392-021-01857-4.
  70. P. Jeemon, T. Séverin, C. Amodeo, D. Balabanova, N. R. C. Campbell, D. Gaita, K. Kario, T. Khan, R. Melifonwu, A. Moran, E. Ogola, P. Ordunez, P. Perel, D. Piñeiro, F. J. Pinto, A. E. Schutte, F. S. Wyss, L. L. Yan, N. R. Poulter, & D. Prabhakaran. (2021). World Heart Federation Roadmap for Hypertension – A 2021 Update. Glob Heart, 16(1), 63. doi:10.5334/gh.1066.
  71. V. Katerenchuk, G. S. Duarte, E. Pereira G. Martins, R. M. Fernandes, J. J. Ferreira, F. J. Pinto, J. Costa, & D. Caldeira. (2021). Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis. Thromb Haemost, 121(3), 366-382. doi:10.1055/s-0040-1716752.
  72. K. Kato, V. L. Cammann, L. C. Napp, K. A. Szawan, J. Micek, S. Dreiding, R. A. Levinson, V. Petkova, M. Wurdinger, A. Patrascu, R. Sumalinog, S. Gili, C. F. Clarenbach, M. Kohler, M. Wischnewsky, R. Citro, C. Vecchione, E. Bossone, M. Neuhaus, J. Franke, B. Meder, M. Jaguszewski, M. Noutsias, M. Knorr, S. Heiner, F. D’Ascenzo, W. Dichtl, C. Burgdorf, B. Kherad, C. Tschope, A. Sarcon, J. Shinbane, L. Rajan, G. Michels, R. Pfister, A. Cuneo, C. Jacobshagen, M. Karakas, W. Koenig, A. Pott, P. Meyer, M. Roffi, A. Banning, M. Wolfrum, F. Cuculi, R. Kobza, T. A. Fischer, T. Vasankari, K. E. J. Airaksinen, M. Budnik, R. Dworakowski, P. MacCarthy, C. Kaiser, S. Osswald, L. Galiuto, C. Chan, P. Bridgman, D. Beug, C. Delmas, O. Lairez, E. Gilyarova, A. Shilova, M. Gilyarov, I. El-Battrawy, I. Akin, M. Kozel, P. Tousek, D. E. Winchester, J. Galuszka, C. Ukena, G. Poglajen, P. Carrilho-Ferreira, C. Hauck, C. Paolini, C. Bilato, M. Sano, I. Ishibashi, M. Takahara, T. Himi, Y. Kobayashi, A. Prasad, C. S. Rihal, K. Liu, P. C. Schulze, M. Bianco, L. Jorg, H. Rickli, G. Pestana, T. H. Nguyen, M. Bohm, L. S. Maier, F. J. Pinto, P. Widimsky, S. B. Felix, G. Opolski, R. C. Braun-Dullaeus, W. Rottbauer, G. Hasenfuss, B. M. Pieske, H. Schunkert, M. Borggrefe, H. Thiele, J. Bauersachs, H. A. Katus, J. D. Horowitz, C. Di Mario, T. Munzel, F. Crea, J. J. Bax, T. F. Luscher, F. Ruschitzka, J. R. Ghadri, & C. Templin. (2021). Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry. ESC Heart Fail, 8(3), 1924-1932. doi:10.1002/ehf2.13165.
  73. Katritsis, V. Luther, N. Cortez-Dias, L. Carpinteiro, J. de Sousa, P. B. Lim, Z. Whinnett, F. S. Ng, M. Koa-Wing, N. Qureshi, A. Chow, S. Agarwal, S. Jamil-Copley, N. S. Peters, N. Linton, & P. Kanagaratnam. (2021). Electroanatomic Characterization and Ablation of Scar-Related Isthmus Sites Supporting Perimitral Flutter. JACC Clin Electrophysiol, 7(5), 578-590. doi:10.1016/j.jacep.2020.10.017.
  74. K. Kotseva, G. De Backer, D. De Bacquer, L. Ryden, A. Hoes, D. Grobbee, A. Maggioni, P. Marques-Vidal, C. Jennings, A. Abreu, C. Aguiar, J. Badariene, J. Bruthans, R. Cifkova, K. Davletov, M. Dilic, M. Dolzhenko, D. Gaita, N. Gotcheva, H. Hasan-Ali, P. Jankowski, C. Lionis, S. Mancas, D. Milicic, E. Mirrakhimov, R. Oganov, N. Pogosova, Z. Reiner, D. Vulic, D. Wood, & Euroaspire V. Investigators. (2021). Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol, 28(4), 370-379. doi:10.1177/2047487320908698.
  75. N. Koval, M. Alves, R. Placido, A. G. Almeida, J. E. Fonseca, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis. RMD Open, 7(2). doi:10.1136/rmdopen-2021-001678.
  76. Lamounier Junior, A. Guitian Gonzalez, A. Rodriguez Vilela, A. Reparaz Andrade, A. Rubio Alcaide, A. Berta Sousa, C. Benito Lopez, D. Alonso Garcia, G. Fernandez Ferro, I. Cruz, I. J. Cardenas Reyes, J. Salazar-Mendiguchia Garcia, J. M. Larranaga-Moreira, J. P. Ochoa, J. Palomino-Doza, L. de la Higuera Romero, M. Nicolas Cicerchia, M. A. Restrepo Cordoba, M. L. Pena-Pena, M. Noel Brogger, M. Loureiro, M. V. Mogollon Jimenez, R. Bilbao Quesada, R. Franco Gutierrez, S. Garcia Hernandez, T. Ripoll-Vera, X. Fernandez, O. Azevedo, P. Garcia Pavia, L. R. Lopes, M. Ortiz, D. Brito, R. Barriales-Villa, & L. Monserrat Iglesias. (2021). Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant. Rev Esp Cardiol (Engl Ed). doi:10.1016/j.rec.2021.01.001.
  77. S. Liprandi, M. I. S. Liprandi, E. J. Zaidel, G. M. Aisenberg, A. Baranchuk, E. C. D. Barbosa, G. B. Sanchez, B. Alexander, F. T. L. Zanetti, R. L. Santi, A. G. Munera-Echeverri, P. Perel, D. Piskorz, C. E. Ruiz-Mori, J. Saucedo, O. Valdez, J. R. G. Juanatey, D. J. Pineiro, F. J. Pinto, & F. S. W. Quintana. (2021). Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart, 16(1), 55. doi:10.5334/gh.1069.
  78. Mainoli, G. S. Duarte, J. Costa, J. Ferreira, & D. Caldeira. (2021). Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis. Am J Cardiovasc Drugs, 21(1), 63-71. doi:10.1007/s40256-020-00409-x.
  79. Marques, I. Cruz, I. Joao, A. R. Almeida, P. Fazendas, D. Caldeira, S. Alegria, A. R. Pereira, A. Briosa, C. Cotrim, L. R. Lopes, & H. Pereira. (2021). The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention. J Am Soc Echocardiogr, 34(1), 51-61. doi:10.1016/j.echo.2020.09.001.
  80. M. Marques Antunes, G. S. Duarte, D. Brito, M. Borges, J. Costa, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes, 7(1), 97-106. doi:10.1093/ehjqcco/qcaa030.
  81. Marques, J. Gameiro, J. Oliveira, J. A. Fonseca, I. Duarte, J. Bernardo, C. Branco, C. Costa, C. Carreiro, S. Braz, & J. A. Lopes. (2021). Acute Kidney Disease and Mortality in Acute Kidney Injury Patients with COVID-19. J Clin Med, 10(19). doi:10.3390/jcm10194599.
  82. P. Marques, A. Nunes-Ferreira, P. Silverio Antonio, I. Aguiar-Ricardo, T. Rodrigues, N. Badie, I. Marcos, A. Bernardes, F. J. Pinto, & J. de Sousa. (2021). Clinical impact of MultiPoint pacing in responders to cardiac resynchronization therapy. Pacing Clin Electrophysiol, 44(9), 1577-1584. doi:10.1111/pace.14319.
  83. E. Pereira G. Martins, S. Duarte G, V. Katerenchuk, J. Costa, C. David, J. J. Ferreira, F. J. Pinto, & D. Caldeira. (2021). Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis. Expert Opin Drug Saf, 20(5), 577-588. doi:10.1080/14740338.2021.1877658.
  84. L. S. Mehta, M. S. V. Elkind, S. Achenbach, F. J. Pinto, & A. Poppas. (2021). Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation. J Am Coll Cardiol, 78(7), 752-756. doi:10.1016/j.jacc.2021.04.043.
  85. L. S. Mehta, M. S. V. Elkind, S. Achenbach, F. J. Pinto, & A. Poppas. (2021). Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field: A Joint Statement from the American College of Cardiology, American Heart Association, European Society of Cardiology, and World Heart Federation. Glob Heart, 16(1), 48. doi:10.5334/gh.1067.
  86. L. S. Mehta, M. S. V. Elkind, S. Achenbach, F. J. Pinto, & A. Poppas. (2021). Clinician Well-Being-Addressing Global Needs for Improvements in the Health Care Field: A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation. Circulation, 144(7), e151-e155. doi:10.1161/CIRCULATIONAHA.121.055748.
  87. L. S. Mehta, M. S. V. Elkind, S. Achenbach, F. J. Pinto, & A. Poppas. (2021). Clinician Well-Being-addressing global needs for improvements in the health care field: a joint opinion from the American College of Cardiology, American Heart Association, European Society of Cardiology, World Heart Federation. Eur Heart J, 42(33), 3122-3126. doi:10.1093/eurheartj/ehab346.
  88. Miranda, C. Sousa, H. Santos, I. Almeida, J. Chin, S. Almeida, & J. Tavares. (2021). What is the real impact of on-site percutaneous coronary intervention? A propensity score analysis of patients admitted with acute coronary syndrome. Rev Port Cardiol (Engl Ed), 40(3), 169-188. doi:10.1016/j.repc.2020.06.019.
  89. Nobre, I. Rocha, C. M. Morin, & M. M. E. Cruz. (2021). Insomnia and circadian misalignment: an underexplored interaction towards cardiometabolic risk. Sleep Sci, 14(1), 55-63. doi:10.5935/1984-0063.20200025.
  90. Ntaios, M. V. Huisman, H. C. Diener, J. L. Halperin, C. Teutsch, S. Marler, V. K. Gurusamy, M. Thompson, G. Y. H. Lip, & B. Olshansky. (2021). Anticoagulant selection in relation to the SAMe-TT(2)R(2) score in patients with atrial fibrillation: The GLORIA-AF registry. Hellenic J Cardiol, 62(2), 152-157. doi:10.1016/j.hjc.2020.11.009.
  91. Nunes-Ferreira, M. Alves, G. Lima da Silva, N. Cortez-Dias, J. de Sousa, F. J. Pinto, & D. Caldeira. (2021). Anticoagulation after typical atrial flutter ablation: Systematic review and meta-analysis. Pacing Clin Electrophysiol, 44(10), 1701-1710. doi:10.1111/pace.14342.
  92. Nunes-Ferreira, A. Bernardes, F. J. Pinto, J. de Sousa, & P. Marques. (2021). When the lead extractor becomes the assistant for new lead implant. Indian Pacing Electrophysiol J, 21(1), 59-61. doi:10.1016/j.ipej.2020.09.006.
  93. Oliveira, J. Gameiro, J. Bernardo, F. Marques, C. Costa, C. Branco, I. Duarte, J. Fonseca, C. Carreiro, S. Braz, & J. A. Lopes. (2021). Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis. J Clin Med, 10(14). doi:10.3390/jcm10143147.
  94. Pascual-Figal, R. Wachter, M. Senni, W. Bao, A. Noe, H. Schwende, D. Butylin, M. F. Prescott, & Transition Investigators. (2020). NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. JACC Heart Fail, 8(10), 822-833. doi:10.1016/j.jchf.2020.05.012.
  95. R. F. E. Pedretti, M. C. Iliou, C. W. Israel, A. Abreu, H. Miljoen, U. Corra, C. Stellbrink, A. B. Gevaert, D. A. Theuns, M. F. Piepoli, R. Reibis, J. P. Schmid, M. Wilhelm, H. Heidbuchel, H. Voller, M. Ambrosetti, T. Deneke, V. Cornelissen, R. Heinzel F, C. H. Davos, G. Kudaiberdieva, I. Frederix, J. H. Svendsen, & D. Hansen. (2021). Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA). Europace, 23(9), 1336-1337o. doi:10.1093/europace/euaa427.
  96. R. F. E. Pedretti, M. C. Iliou, C. W. Israel, A. Abreu, H. Miljoen, U. Corra, C. Stellbrink, A. B. Gevaert, D. A. Theuns, M. F. Piepoli, R. Reibis, J. P. Schmid, M. Wilhelm, H. Heidbuchel, H. Voller, reviewers Document, M. Ambrosetti, T. Deneke, V. Cornelissen, R. Heinzel F, C. H. Davos, G. Kudaiberdieva, I. Frederix, J. H. Svendsen, & D. Hansen. (2021). Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA). Eur J Prev Cardiol. doi:10.1093/eurjpc/zwaa121.
  97. Pereira, R. Cale, E. Pereira, S. Mello, S. Vitorino, P. Jeronimo de Sousa, S. Monteiro, F. J. Pinto, R. Ramos, P. Coelho Dos Santos, J. Ferreira, J. Silveira, J. Morais, & Portugal centers participating in the ‘Stent for Life’ Initiative. (2021). Five years of Stent for Life in Portugal. Rev Port Cardiol (Engl Ed), 40(2), 81-90. doi:10.1016/j.repc.2020.05.018.
  98. T. Pereira-da-Silva, V. Ferreira, A. Castelo, D. Caldeira, P. Napoleao, T. Pinheiro, R. C. Ferreira, & M. M. Carmo. (2021). Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis. Atherosclerosis, 319, 86-100. doi:10.1016/j.atherosclerosis.2020.12.011.
  99. Fausto J. Pinto. (2021). Gender Equity: Time to Act. International Journal of Cardiovascular Sciences, 34(4), 340-341. doi:10.36660/ijcs.20210183.
  100. F. J. Pinto. (2021). World Heart Day 2021 from the President of the World Heart Federation. Am J Physiol Lung Cell Mol Physiol, 321(3), L631-L633. doi:10.1152/ajplung.00338.2021.
  101. F. J. Pinto, K. Armstrong-Walenczak, & K. Sliwa. (2021). Climate Action for Health: An Urgent Call from the Global Cardiovascular Community. Glob Heart, 16(1), 33. doi:10.5334/gh.1051.
  102. R. Pinto, M. L. Pires, M. Borges, M. L. Pinto, C. S. Guerreiro, S. Miguel, O. Santos, I. Ricardo, N. Cunha, P. A. D. Silva, A. L. Correia, S. Fiúza, E. Caldeira, F. Salazar, C. Rodrigues, M. C. Ferreira, G. Afonso, G. Araújo, J. Martins, M. Ramalhinho, P. Sousa, S. Pires, A. Jordão, F. J. Pinto, & A. Abreu. (2021). [Digital home-based multidisciplinary cardiac rehabilitation: How to counteract physical inactivity during the COVID-19 pandemic]. Rev Port Cardiol. doi:10.1016/j.repc.2021.05.013.
  103. Vanda Pinto, Augusto Ministro, Nuno Reis Carreira, Ana Cardoso, Catarina Sousa Gonçalves, Mickael Henriques, João Rato, Emanuel Silva, & Luís Mendes Pedro. (2021). A catastrophic seronegative anti-phospholipid syndrome: case and literature review. Thrombosis Journal, 19(1), 103. doi:10.1186/s12959-021-00356-w.
  104. R. Placido, A. G. Almeida, & F. J. Pinto. (2020). Multisite embolic events secondary to pulmonary valve endocarditis. Eur Heart J Cardiovasc Imaging, 21(12), 1432. doi:10.1093/ehjci/jeaa132.
  105. R. Plácido, T. Guimarães, D. Jenkins, N. Cortez-Dias, S. C. Pereira, P. Campos, A. Mineiro, N. Lousada, S. R. Martins, S. Moreira, A. R. Dias, C. L. Resende, R. Vieira, & F. J. Pinto. (2021). Chronic thromboembolic pulmonary hypertension: Initial experience of patients undergoing pulmonary thromboendarterectomy. Rev Port Cardiol (Engl Ed), 40(10), 741-752. doi:10.1016/j.repce.2021.08.002.
  106. L. Prada, D. Santos C, R. A. Baiao, J. Costa, J. J. Ferreira, & D. Caldeira. (2021). Risk of SARS-CoV-2 Infection and COVID-19 Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis. J Clin Pharmacol, 61(12), 1521-1533. doi:10.1002/jcph.1949.
  107. Luís Raposo, Mariana Gonçalves, David Roque, Pedro Araújo Gonçalves, Pedro Magno, João Brito, Sílvio Leal, Sérgio Madeira, Miguel Santos, Rui Campante Teles, Pedro Farto e Abreu, Manuel Almeida, Carlos Morais, Miguel Mendes, & Sérgio Bravo Baptista. (2021). Adoption and patterns of use of invasive physiological assessment of coronary artery disease in a large cohort of 40<span class=”elsevierStyleHsp” style=””></span>821 real-world procedures over a 12-year period. Revista Portuguesa de Cardiologia, 40(10), 771-781. doi:10.1016/j.repc.2021.01.010. 10.1016/j.repc.2021.01.010.
  108. F. Reis, M. Alves, & D. Caldeira. (2021). Cochrane Corner: Withdrawal of antihypertensive drugs in older people. Rev Port Cardiol (Engl Ed), 40(5), 391-393. doi:10.1016/j.repc.2020.11.008.
  109. Richter, L. Guasti, D. Walker, E. Lambrinou, C. Lionis, A. Abreu, I. Savelieva, S. Fumagalli, M. Bo, B. Rocca, M. T. Jensen, L. Pierard, I. Sudano, V. Aboyans, & R. Asteggiano. (2021). Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol. doi:10.1093/eurjpc/zwaa167.
  110. Rigueira, I. Aguiar-Ricardo, P. Carrilho-Ferreira, M. N. Menezes, S. Pereira, P. S. Morais, P. C. D. Silva, & F. J. Pinto. (2021). Predictors of coronary artery disease in cardiac arrest survivors: coronary angiography for everyone? A single-center retrospective analysis. Rev Bras Ter Intensiva, 33(2), 251-260. doi:10.5935/0103-507x.20210032.
  111. Rigueira, R. Agostinho J, I. Aguiar-Ricardo, I. Goncalves, R. Santos, A. Nunes-Ferreira, T. Rodrigues, N. Cunha, N. Andre, R. Pires, F. Veiga, M. Mendes Pedro, F. J. Pinto, & D. Brito. (2021). Heart and brain interactions in heart failure: Cognition, depression, anxiety, and related outcomes. Rev Port Cardiol (Engl Ed), 40(8), 547-555. doi:10.1016/j.repce.2020.09.008.
  112. S. Rodrigues, M. Alves, G. S. Duarte, J. Costa, F. J. Pinto, & D. Caldeira. (2021). The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews. Trends Cardiovasc Med, 31(5), 315-320. doi:10.1016/j.tcm.2020.06.003.
  113. T. Rodrigues, S. C. Raposo, D. Brito, & L. R. Lopes. (2021). Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review. Int J Cardiol, 339, 83-92. doi:10.1016/j.ijcard.2021.06.051.
  114. G. M. C. Rosano, B. Moura, M. Metra, M. Bohm, J. Bauersachs, T. Ben Gal, S. Adamopoulos, M. Abdelhamid, V. Bistola, J. Celutkiene, O. Chioncel, D. Farmakis, R. Ferrari, G. Filippatos, L. Hill, E. A. Jankowska, T. Jaarsma, P. Jhund, M. Lainscak, Y. Lopatin, L. H. Lund, D. Milicic, W. Mullens, F. Pinto, P. Ponikowski, G. Savarese, T. Thum, M. Volterrani, S. D. Anker, P. M. Seferovic, & A. J. S. Coats. (2021). Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 23(6), 872-881. doi:10.1002/ejhf.2206.
  115. Catarina M. Dos Santos, Luísa Prada, Cláudio David, João Costa, Joaquim J. Ferreira, Fausto J. Pinto, & Daniel Caldeira. (2021). Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them? TH open : companion journal to thrombosis and haemostasis, 5(2), e125-e133. doi:10.1055/s-0041-1725043.
  116. Santos, I. Rocha, D. Gozal, & E. Cruz M. Meira. (2020). Obstructive sleep apnea, shift work and cardiometabolic risk. Sleep Med, 74, 132-140. doi:10.1016/j.sleep.2020.05.013.
  117. BV Silva, J Brito, T Rodrigues, P Silverio Antonio, S Couto Pereira, P Alves Da Silva, G Lima Da Silva, N Cunha, P Teixeira, L Carpinteiro, N Cortez -Dias, FJ Pinto, & J Sousa. (2021). The pacemaker ventricular lead position and outcomes in patients upgrading to crt. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.452.
  118. P. Silva, Tárik Augusto Rodrigues, Nelson Cunha, J. Brito, Sara Couto Pereira, A. Nunes-Ferreira, P. Silverio-Antonio, B. Valente-Silva, C. Barreiros, Luis Carpinteiro, Nuno Cortez-Dias, Fausto Pinto, & Joao Sousa. (2021). Typical atrial flutter ablation and predictors of events in the follow-up. EP Europace, 23. doi:10.1093/europace/euab116.306.
  119. P. Silva, Tárik Augusto Rodrigues, Nelson Cunha, J. Brito, Sara Couto Pereira, A. Nunes-Ferreira, P. Silverio-Antonio, B. Valente-Silva, C. Barreiros, Luis Carpinteiro, Nuno Cortez-Dias, Fausto Pinto, & Joao Sousa. (2021). Typical atrial flutter ablation and predictors of events in the follow-up. EP Europace, 23. doi:10.1093/europace/euab116.306.
  120. Silva-Cardoso, A. Andrade, D. Brito, J. Ferreira, C. Fonseca, M. Peres, F. Franco, & B. Moura. (2021). SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction. Rev Port Cardiol (Engl Ed), 40(9), 687-693. doi:10.1016/j.repce.2021.02.006.
  121. Silva-Cardoso, D. Brito, J. M. Frazao, A. Ferreira, P. Bettencourt, P. Branco, & C. Fonseca. (2021). Management of RAASi-associated hyperkalemia in patients with cardiovascular disease. Heart Fail Rev, 26(4), 891-896. doi:10.1007/s10741-020-10069-3.
  122. Silva-Cardoso, C. Fonseca, F. Franco, J. Morais, J. Ferreira, & D. Brito. (2021). Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper. Rev Port Cardiol (Engl Ed). doi:10.1016/j.repc.2021.07.009.
  123. P Silverio Antonio, T Rodrigues, J Brito, S Pereira, B Valente Silva, P Alves Da Silva, N Cunha, A Nunes-Ferreira, A Bernardes, G Lima Da Silva, L Carpinteiro, N Cortez-Dias, F J Pinto, & J De Sousa. (2021). Early discharge after cryoablation procedure: is it safe? EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.181.
  124. Sliwa, K. Singh, L. Raspail, D. Ojji, C. S. P. Lam, F. Thienemann, J. Ge, A. Banerjee, L. K. Newby, A. L. P. Ribeiro, S. Gidding, F. Pinto, P. Perel, & D. Prabhakaran. (2021). The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. Glob Heart, 16(1), 22. doi:10.5334/gh.950.
  125. Sokolski, P. Gajewski, R. Zymlinski, J. Biegus, J. M. T. Berg, W. Bor, F. Braunschweig, D. Caldeira, F. Cuculi, E. D’Elia, I. F. Edes, M. Garus, J. P. Greenwood, F. R. Halfwerk, G. Hindricks, J. Knuuti, S. D. Kristensen, U. Landmesser, L. H. Lund, A. Lyon, A. Mebazaa, B. Merkely, S. Nawrocka-Millward, F. J. Pinto, F. Ruschitzka, E. Semedo, M. Senni, A. Sepehri Shamloo, J. Sorensen, C. Stengaard, H. Thiele, S. Toggweiler, A. Tukiendorf, P. M. Verhorst, D. J. Wright, P. Zamorano, M. Zuber, J. Narula, J. J. Bax, & P. Ponikowski. (2021). Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe. Am J Med, 134(4), 482-489. doi:10.1016/j.amjmed.2020.08.043.
  126. Catarina Sousa. (2021). Climacteric Period and Cardiovascular risk: a Golden Opportunity to Watch and Succeed! International Journal of Cardiovascular Sciences, 34(4), 398-399. doi:10.36660/ijcs.20210159.
  127. Sousa, P. Nogueira, & F. J. Pinto. (2021). Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018. BMC Cardiovasc Disord, 21(1), 138. doi:10.1186/s12872-021-01937-3.
  128. Catarina Sousa, Paulo Jorge Nogueira, & Fausto J. Pinto. (2021). Gender Based Analysis of a Population Series of Patients Hospitalized with Infective Endocarditis in Portugal – How do Women and Men Compare? International Journal of Cardiovascular Sciences, 34(4), 347-355. doi:10.36660/ijcs.20210032.
  129. Catarina Sousa, & Fausto Pinto. (2021). COVID-19 and Medical Education: A Window to New Opportunities. Lusiadas Scientific Journal, 2(2), 52-53.
  130. R. Teerlink, R. Diaz, G. M. Felker, J. J. V. McMurray, M. Metra, S. D. Solomon, K. F. Adams, I. Anand, A. Arias-Mendoza, T. Biering-Sorensen, M. Bohm, D. Bonderman, J. G. F. Cleland, R. Corbalan, M. G. Crespo-Leiro, U. Dahlstrom, L. E. Echeverria, J. C. Fang, G. Filippatos, C. Fonseca, E. Goncalvesova, A. R. Goudev, J. G. Howlett, D. E. Lanfear, J. Li, M. Lund, P. Macdonald, V. Mareev, S. I. Momomura, E. O’Meara, A. Parkhomenko, P. Ponikowski, F. J. A. Ramires, P. Serpytis, K. Sliwa, J. Spinar, T. M. Suter, J. Tomcsanyi, H. Vandekerckhove, D. Vinereanu, A. A. Voors, M. B. Yilmaz, F. Zannad, L. Sharpsten, J. C. Legg, C. Varin, N. Honarpour, S. A. Abbasi, F. I. Malik, C. E. Kurtz, & Galactic-Hf Investigators. (2021). Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N Engl J Med, 384(2), 105-116. doi:10.1056/NEJMoa2025797.
  131. Valente Silva, R. Plácido, C. Jorge, C. Mendonça, M. L. Urbano, T. Rodrigues, J. Brito, P. Alves da Silva, J. Rigueira, & F. J. Pinto. (2021). Prognostic Accuracy of the Modified CHA2DS2-VASc Score in COVID-19 Patients Admitted to the Emergency Department Due to Clinical Worsening. Acta Med Port. doi:10.20344/amp.1701
  132. Vamvakidou, M. S. Annabi, P. Pibarot, E. Plonska-Gosciniak, A. G. Almeida, E. Guzzetti, A. Dahou, I. G. Burwash, M. Koschutnik, P. E. Bartko, J. Bergler-Klein, J. Mascherbauer, S. Orwat, H. Baumgartner, J. Cavalcante, F. Pinto, T. Kukulski, J. D. Kasprzak, M. A. Clavel, F. A. Flachskampf, & R. Senior. (2021). Clinical Value of Stress Transaortic Flow Rate During Dobutamine Echocardiography in Reduced Left Ventricular Ejection Fraction, Low-Gradient Aortic Stenosis: A Multicenter Study. Circ Cardiovasc Imaging, 14(11), e012809. doi:10.1161/circimaging.121.012809.
  133. R. Vanholder, E. Rondeau, H. J. Anders, N. Carlson, D. Fliser, M. Kanbay, J. António Lopes, P. T. Murray, A. Ortiz, A. B. Sanz, N. M. Selby, A. Wiecek, & Z. A. Massy. (2021). EDTAKI: A Nephrology and Public Policy Committee (NPPC) Platform Call for More European Involvement in AKI. Nephrol Dial Transplant. doi:10.1093/ndt/gfab018.
  134. T. R. Velho, J. M. Goncalves, R. M. Pereira, R. M. da Cruz, N. C. Guerra, R. Ferreira, & A. Nobre. (2021). Primary cardiac hydatic cyst with multiple locations: an unusual case of chest pain. Gen Thorac Cardiovasc Surg, 69(7), 1147-1150. doi:10.1007/s11748-021-01631-3.
  135. Vouga Ribeiro, R. Gouveia Melo, N. C. Guerra, A. Nobre, R. M. Fernandes, L. M. Pedro, J. Costa, F. J. Pinto, & D. Caldeira. (2021). Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis. Semin Thorac Cardiovasc Surg, 33(4), 907-918. doi:10.1053/j.semtcvs.2020.11.011.
  136. R. P. Whitlock, E. P. Belley-Cote, D. Paparella, J. S. Healey, K. Brady, M. Sharma, W. Reents, P. Budera, A. J. Baddour, P. Fila, P. J. Devereaux, A. Bogachev-Prokophiev, A. Boening, K. H. T. Teoh, G. I. Tagarakis, M. S. Slaughter, A. G. Royse, S. McGuinness, M. Alings, P. P. Punjabi, C. D. Mazer, R. J. Folkeringa, A. Colli, A. Avezum, J. Nakamya, K. Balasubramanian, J. Vincent, P. Voisine, A. Lamy, S. Yusuf, S. J. Connolly, & Laaos Iii Investigators. (2021). Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N Engl J Med, 384(22), 2081-2091. doi:10.1056/NEJMoa2101897.
  137. Wilhelm, A. Abreu, P. E. Adami, M. Ambrosetti, M. Antonopoulou, A. Biffi, E. Cavarretta, F. D’Ascenzi, I. Gibson, D. E. Grobbee, M. C. Iliou, K. Koskinas, P. Marques-Vidal, U. Nixdorff, M. Papadakis, M. F. Piepoli, V. Vassiliou, D. Wood, P. Dendale, & M. Halle. (2021). EAPC Core Curriculum for Preventive Cardiology. Eur J Prev Cardiol. doi:10.1093/eurjpc/zwab017.
  138. J. Willett, S. Achenbach, F. J. Pinto, A. Poppas, & M. S. V. Elkind. (2021). The Tobacco Endgame: Eradicating a Worsening Epidemic A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. J Am Coll Cardiol, 78(1), 77-81. doi:10.1016/j.jacc.2021.04.005.
  139. J. Willett, S. Achenbach, F. J. Pinto, A. Poppas, & M. S. V. Elkind. (2021). The Tobacco Endgame-Eradicating a Worsening Epidemic: A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. Circulation, 144(1), e1-e5. doi:10.1161/CIRCULATIONAHA.121.054369.
  140. J. Willett, S. Achenbach, F. J. Pinto, A. Poppas, & M. S. V. Elkind. (2021). The Tobacco Endgame-Eradicating a Worsening Epidemic: A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. Glob Heart, 16(1), 40. doi:10.5334/gh.1061.
  141. J. Willett, S. Achenbach, F. J. Pinto, A. Poppas, & M. S. V. Elkind. (2021). The Tobacco Endgame-Eradicating a Worsening Epidemic: A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. Glob Heart, 16(1), 40. doi:10.5334/gh.1061.
  142. B. Wu, E. S. Brilakis, K. Mashayekhi, E. Tsuchikane, K. Alaswad, M. Araya, A. Avran, L. Azzalini, A. M. Babunashvili, B. Bayani, M. Behnes, R. Bhindi, N. Boudou, M. Boukhris, N. Z. Bozinovic, L. Bryniarski, A. Bufe, C. E. Buller, M. N. Burke, A. Buttner, P. Cardoso, M. Carlino, J. Y. Chen, E. H. Christiansen, A. Colombo, K. Croce, F. D. de Los Santos, T. de Martini, J. Dens, C. di Mario, K. Dou, M. Egred, B. Elbarouni, A. M. ElGuindy, J. Escaned, S. Furkalo, A. Gagnor, A. R. Galassi, R. Garbo, G. Gasparini, J. Ge, L. Ge, P. K. Goel, O. Goktekin, N. Gonzalo, L. Grancini, A. Hall, F. L. Hanna Quesada, C. Hanratty, S. Harb, S. A. Harding, R. Hatem, J. P. S. Henriques, D. Hildick-Smith, J. M. Hill, A. Hoye, W. Jaber, F. A. Jaffer, Y. Jang, R. Jussila, A. Kalnins, A. Kalyanasundaram, D. E. Kandzari, H. L. Kao, D. Karmpaliotis, H. H. Kassem, J. Khatri, P. Knaapen, R. Kornowski, O. Krestyaninov, A. V. G. Kumar, P. M. Lamelas, S. W. Lee, T. Lefevre, R. Leung, Y. Li, Y. Li, S. T. Lim, S. Lo, W. Lombardi, A. Maran, M. McEntegart, J. Moses, M. Munawar, A. Navarro, H. M. Ngo, W. Nicholson, A. Oksnes, G. K. Olivecrona, L. Padilla, M. Patel, A. Pershad, M. Postu, J. Qian, A. Quadros, N. A. Rafeh, T. Ramunddal, V. S. Prakasa Rao, N. Reifart, R. F. Riley, S. Rinfret, M. Saghatelyan, G. Sianos, E. Smith, A. Spaedy, J. Spratt, G. Stone, J. W. Strange, K. O. Tammam, C. A. Thompson, A. Toma, J. A. Tremmel, R. S. Trinidad, I. Ungi, M. Vo, V. H. Vu, S. Walsh, G. Werner, J. Wojcik, J. Wollmuth, B. Xu, M. Yamane, L. F. Ybarra, R. W. Yeh, & Q. Zhang. (2021). Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol, 78(8), 840-853. doi:10.1016/j.jacc.2021.05.055.
  143. J. L. Zamorano, F. J. Pinto, J. Solano-Lopez, & C. Bucciarelli-Ducci. (2021). The year in cardiovascular medicine 2020: imaging. Eur Heart J, 42(7), 740-749. doi:10.1093/eurheartj/ehaa1035.